Creative Planning Sells 5,328 Shares of Docusign Inc. $DOCU

Creative Planning lowered its holdings in shares of Docusign Inc. (NASDAQ:DOCU) by 18.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,883 shares of the company’s stock after selling 5,328 shares during the period. Creative Planning’s holdings in Docusign were worth $1,782,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. American Century Companies Inc. increased its stake in shares of Docusign by 3.1% in the 1st quarter. American Century Companies Inc. now owns 5,477,758 shares of the company’s stock valued at $445,890,000 after acquiring an additional 162,299 shares in the last quarter. Geode Capital Management LLC grew its holdings in Docusign by 1.5% in the second quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company’s stock worth $309,910,000 after purchasing an additional 59,941 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Docusign by 18.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company’s stock worth $165,120,000 after purchasing an additional 318,698 shares during the period. Wellington Management Group LLP increased its stake in Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock valued at $148,714,000 after purchasing an additional 1,440,269 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Docusign by 6.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,431,901 shares of the company’s stock valued at $116,557,000 after purchasing an additional 89,948 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Robert W. Baird raised their target price on Docusign from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Friday, September 5th. Royal Bank Of Canada raised their price objective on Docusign from $90.00 to $95.00 and gave the company a “sector perform” rating in a research note on Friday, September 5th. Morgan Stanley upped their target price on Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, September 8th. Bank of America increased their target price on Docusign from $85.00 to $102.00 and gave the stock a “neutral” rating in a report on Friday, September 5th. Finally, Wells Fargo & Company lifted their price target on shares of Docusign from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Friday, September 5th. Four analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $94.14.

Docusign Stock Up 1.3%

DOCU stock opened at $68.87 on Thursday. The firm has a market capitalization of $13.85 billion, a PE ratio of 51.78, a P/E/G ratio of 3.38 and a beta of 1.01. Docusign Inc. has a twelve month low of $63.50 and a twelve month high of $107.86. The stock’s 50 day moving average is $71.55 and its 200-day moving average is $76.22.

Docusign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The business had revenue of $800.64 million during the quarter, compared to analyst estimates of $780.35 million. During the same period in the prior year, the firm posted $0.97 EPS. Docusign’s quarterly revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities research analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Blake Jeffrey Grayson sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total transaction of $462,800.00. Following the transaction, the chief financial officer directly owned 105,660 shares of the company’s stock, valued at $7,522,992. This trade represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider James P. Shaughnessy sold 7,500 shares of the company’s stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $71.19, for a total transaction of $533,925.00. Following the completion of the sale, the insider directly owned 55,442 shares of the company’s stock, valued at $3,946,915.98. The trade was a 11.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 102,533 shares of company stock valued at $7,709,933 over the last 90 days. 1.01% of the stock is currently owned by company insiders.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.